Ginkgo Bioworks (DNA) news

Ginkgo Bioworks Holdings, Inc.: TD Cowen raises target price to $11 from $9

TD Cowen has revised its price target for Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), raising it from $9 to $11 per share, reflecting a more optimistic outlook on the company’s near-term prospects. The adjustment follows recent developments in Ginkgo’s business strategy and operational performance,…

Ginkgo Bioworks to provide autonomous lab access to NSF X-Labs researchers, contributing cloud lab time and protein testing services to $1.5 billion breakthrough science program

Ginkgo Bioworks (NYSE: DNA) has announced its participation in the National Science Foundation’s (NSF) X-Labs initiative, a $1.5 billion program aimed at accelerating breakthrough scientific research through interdisciplinary collaboration and advanced technological infrastructure. As part of its…

Ginkgo DataPoints announces partnership with Tunnelab to close the gap between AI models and lab data

Ginkgo Bioworks (NYSE: DNA) has announced a partnership with Tunnelab to enhance the integration of artificial intelligence (AI) with laboratory data generation, addressing a critical challenge in the biotechnology sector. The collaboration aims to streamline the process of training AI models by…

Ginkgo Bioworks Holdings, - Awarded subcontract for up to $17.50 mln under ARPA-H give program

Cronos Group 1Q EPS 4.0c

Cronos Group Inc. (NASDAQ:CRON) reported first-quarter earnings per share of 4.0 cents for the period ending March 31, 2026. The Canadian cannabis company, which operates across the full value chain of cannabis cultivation, production, and distribution, continues to focus on innovation and…